AMX0035 and oral edaravone for amyotrophic lateral sclerosis
Makam AN, Suh K, Nikitin D, Carlson JJ, Richardson M, Mohammed R, McKenna A, Pearson SD, Rind DM
Record ID 32018005189
English
Details
Project Status:
Completed
Year Published:
2022
URL for published report:
https://icer.org/wp-content/uploads/2022/02/ICER-ALS-Final-Report-09132022.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Amyotrophic Lateral Sclerosis
- Edaravone
- Cost-Benefit Analysis
- Phenylbutyrates
- Neuroprotective Agents
- Free Radical Scavengers
Contact
Organisation Name:
Institute for Clinical and Economic Review
Contact Address:
101 Merrimac St., 10th FL., Boston MA, USA 02114, Tel: (617) 724-4445 , Fax: (617) 726-9414
Contact Name:
info@icer-review.org
Contact Email:
info@icer-review.org
Copyright:
<p>Institute for Clinical and Economic Review (ICER)</p>
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.